![](/img/cover-not-exists.png)
6132 POSTER Efficacy of Panitumumab Plus FOLFIRI Versus FOLFIRI Alone in Patients With Wild-Type (WT) KRas Metastatic Colorectal Cancer (mCRC) Treated With Prior Oxaliplatin or Bevacizumab Regimens: Results From 20050181
Price, T., Peeters, M., Strickland, A., Ciuleanu, T.E., Scheithauer, W., O'Reilly, S., Keane, M., Spigel, D., Tian, Y., Kartik, K.Volume:
47
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(11)71777-4
Date:
September, 2011
File:
PDF, 61 KB
english, 2011